In addition, BMP4 overexpression did not change the protein level of APP at 1 month and 3 months of age of transgenic mice (Fig. 2A), indicating that BMP4 overexpression-induced Alzheimer’s disease needs a progressive process. This evidence concerns the gene BMP4 and early-onset autosomal dominant Alzheimer disease.